← Back to headlines
Evommune, Inc. Reports GAAP EPS of -$0.89
Evommune, Inc. released its financial statement, showing a GAAP EPS of -$0.89 for the period.
7 Aug, 13:59 — 7 Aug, 13:59
Sources
Showing 1 of 1 sources
Evommune, Inc. released its financial statement, showing a GAAP EPS of -$0.89 for the period.